Assessment Of Changes In Laboratory Indicators After Treatment In Patients Undergoing Hemodyalysis

dc.contributor.authorRIZAEV Jasur Alimjanovich
dc.contributor.authorGADAYEV Abdigaffor Gadayevich
dc.contributor.authorMAKHMANOV Lutfullo Saydullayevich
dc.date.accessioned2026-02-20T20:49:14Z
dc.date.issued2026-02-14
dc.description.abstractThe article presents a comparative study of laboratory indicators in patients undergoing hemodialysis following complex treatment procedures. The results demonstrate that during renal replacement therapy, patients continue to experience deficiencies in hemoglobin, albumin, calcium, and vitamin D. Conversely, the study shows persistently elevated levels of leukocytes, urea, creatinine, parathyroid hormone, and fibroblast growth factor-23 in the blood serum. These findings emphasize the necessity of an individualized approach to addressing these issues for each patient.
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/7320
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/116383
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/7320/6029
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceEurasian Medical Research Periodical; Vol. 53 (2026): EMRP; 13-23
dc.source2795-7624
dc.subjecthealth care system
dc.subjecthemodialysis
dc.subjectchronic kidney disease
dc.titleAssessment Of Changes In Laboratory Indicators After Treatment In Patients Undergoing Hemodyalysis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
alimjanovich_2026_assessment_of_changes_in_laboratory_indi.pdf
item.page.filesection.size
486.54 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections